Gene Editing as a Potential Therapeutic Solution for Fuchs Endothelial Corneal Dystrophy: The Future Is Clearer

JAMA Ophthalmol. 2018 Sep 1;136(9):969-970. doi: 10.1001/jamaophthalmol.2018.2324.

Authors

Angela Y Zhu¹, Vinod Jaskula-Ranga², Albert S Jun¹

Affiliations

¹ Wilmer Eye Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland.
² Hunterian Medicine, Cambridge, Massachusetts.

PMID: 29931030
DOI: 10.1001/jamaophthalmol.2018.2324

No abstract available

MeSH terms

Fuchs' Endothelial Dystrophy / genetics
Fuchs' Endothelial Dystrophy / therapy*
Gene Editing / methods*
Humans
Transcription Factor 4 / genetics

Substances

TCF4 protein, human
Transcription Factor 4